Latest filing published 27 Mar 2017 for ImmunityBio, Inc., €6,304.
Insider track record
Richard J. Tajak: trading record in brief
All filings by Richard J. Tajak on record concern ImmunityBio, Inc. We count 8 filings; the first trade dates from 23 June 2016 and the latest from 23 March 2017.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 27 March 2017 came the latest disclosure, a share grant for €6,304 in ImmunityBio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard J. Tajak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,983 shares@ US$3.4316.3% of flowCommon StockSEC:0001209191-17-022924:1
- 5,000 shares0Common StockSEC:0001209191-17-022924:0
- 5,000 shares0Common StockSEC:0001209191-16-156930:0
- 1,717 shares@ US$6.1526.2% of flowCommon StockSEC:0001209191-16-156930:1
- 5,000 shares0Common StockSEC:0001209191-16-142963:0
- 1,717 shares@ US$7.9131.3% of flowCommon StockSEC:0001209191-16-142963:1
- 5,000 shares0Common StockSEC:0001209191-16-129789:0
- 1,708 shares@ US$6.7326.2% of flowCommon StockSEC:0001209191-16-129789:1
8 of 8 declarations
